OptiBiotix Signs Major Supply Agreement for its Microbiome Modulating Cholesterol-Reduction Probiotic

d6d4fdd0-bcf5-4480-8f73-4ee148db27dbarticleimage.jpg

19 Jun 2017 --- Life sciences company OptiBiotix has signed a three-year supply agreement with HLH BioPharma Vertriebs GmbH for its cholesterol-reducing LPLDL probiotic supplement. Research into the LPLDL probiotic, presented at Vitafoods Europe in May 2017, demonstrated that it is a safe natural ingredient which reduces blood pressure and cholesterol, key determinates of cardiovascular risk. 

According to the company, the probiotic was found to reduce LDL cholesterol by up to 13.9%, and blood pressure by 5.1%. This research was carried out by Glenn Gibson, Professor of Food Microbiology, Head of Food Microbial Sciences at University of Reading.

Stephen O’Hara, CEO of OptiBiotix, comments, “The development of our LPLDL probiotic product has made cholesterol reduction through microbiome modulation a reality, and we are thrilled to be working with HLH, one of Europe’s leading suppliers to the pharmacy market, on this product. The ability to create designer active ingredients which can modify an individual’s microbiome to improve health places OptiBiotix at the forefront of global microbiome research and product development, and we anticipate many more opportunities for the LPLDL probiotic.”

Microbiome modulators in the form of probiotic supplements, like LPLDL, may be the way forward for managing long-term conditions like cardiovascular disease (CVD). The reduction of both LDL cholesterol and blood pressure is key for managing the risk of CVD. The combination of high blood pressure and cholesterol deposition may lead to the chronic inflammation and hardening of the walls of the blood vessels, which greatly increases the probability of suffering a cardiovascular event. Recent research, presented at the European Society of Cardiology Congress 2016, demonstrated that reducing LDL cholesterol and blood pressure can reduce the lifetime risk of cardiovascular disease by nearly 90%.

The supply agreement grants HLH a non-exclusive license to produce, package, and commercialize products containing the LPLDL strain, and follows HLH’s recent order for 100,000 units of LPLDL. HLH has over 20 years’ experience in the distribution of probiotic and natural products under the brand names Lactobact and Casa Sana and is one of Europe’s leading suppliers of probiotics to the pharmacy market. LPLDL will be supplied as bulk capsules which will be packaged and branded as part of HLH’s market leading Lactobact brand.

Related Articles

Nutrition & Health News

Satiety: Mushrooms may trump meat in helping to feel fuller for longer

19 Oct 2017 --- If breakfast is the most important meal of the day, then a new Mushroom Council-funded study suggests mushrooms may be one of the most important ingredients. The study on satiety, published in the October issue of the journal Appetite, indicates that eating a mushroom-rich breakfast may result in less hunger and a greater feeling of fullness after a mushroom breakfast compared to a meat breakfast.

Nutrition & Health News

Health claims on snack bar packaging lead to better consumer sensory acceptance: study

19 Oct 2017 --- A study looking into the influence of package and health-related claims on perception and sensory acceptability of snack bars has found that when health claims were given to consumers, a better sensory acceptance was observed. Among other findings, package attributes, price and flavor were also highlighted on purchase intention of bars.

Nutrition & Health News

Golden opportunities: SternLife taps into turmeric trend with drinks and capsules

19 Oct 2017 --- SternLife has launched two curcuma latte options, aimed at fitness-minded and health-conscious aficionados, as well as curcuma capsules that help with weight management. 

 

Nutrition & Health News

Brussels sprouts and green tea could convert breast cancer from lethal to treatable form

19 Oct 2017 --- Researchers at the University of Alabama at Birmingham (UAB) have found a dietary combination that transforms the most lethal of all breast cancers into a highly treatable breast cancer. Specifically, scientists involved in the Scientific Reports study say sulforaphane – from cruciferous vegetables such as broccoli sprouts – along with polyphenols from green tea may be the key.

Nutrition & Health News

European parents increasingly turning to charities for meals, survey reveals

19 Oct 2017 --- A new survey by commissioned by Kellogg, has revealed that families are struggling to afford a balanced and healthy diet, and are increasingly reliant on Breakfast Clubs, foodbanks and charities, especially during school holidays. 

 

More Articles
URL : http://www.nutritioninsight.com:80/news/optibiotix-signs-major-supply-agreement-for-its-microbiome-modulating-cholesterol-reduction-probiotic.html